1. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis;Anaya;The Journal of Rheumatology,1994
2. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate;Carroll;The Journal of Rheumatology,1994
3. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate;Carson;Seminars in Arthritis and Rheumatism,1987
4. Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients;Combe;British Journal of Rheumatology,1995
5. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis;Fathi;The Journal of Rheumatology,2002